rs9332801

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001197104.2(KMT2A):​c.4284A>C​(p.Ile1428Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0571 in 1,613,484 control chromosomes in the GnomAD database, including 2,973 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.042 ( 185 hom., cov: 32)
Exomes 𝑓: 0.059 ( 2788 hom. )

Consequence

KMT2A
NM_001197104.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.77

Publications

17 publications found
Variant links:
Genes affected
KMT2A (HGNC:7132): (lysine methyltransferase 2A) This gene encodes a transcriptional coactivator that plays an essential role in regulating gene expression during early development and hematopoiesis. The encoded protein contains multiple conserved functional domains. One of these domains, the SET domain, is responsible for its histone H3 lysine 4 (H3K4) methyltransferase activity which mediates chromatin modifications associated with epigenetic transcriptional activation. This protein is processed by the enzyme Taspase 1 into two fragments, MLL-C and MLL-N. These fragments reassociate and further assemble into different multiprotein complexes that regulate the transcription of specific target genes, including many of the HOX genes. Multiple chromosomal translocations involving this gene are the cause of certain acute lymphoid leukemias and acute myeloid leukemias. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
KMT2A Gene-Disease associations (from GenCC):
  • Wiedemann-Steiner syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Illumina, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 11-118484927-A-C is Benign according to our data. Variant chr11-118484927-A-C is described in ClinVar as Benign. ClinVar VariationId is 158702.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.77 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0622 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2ANM_001197104.2 linkc.4284A>C p.Ile1428Ile synonymous_variant Exon 10 of 36 ENST00000534358.8 NP_001184033.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2AENST00000534358.8 linkc.4284A>C p.Ile1428Ile synonymous_variant Exon 10 of 36 1 NM_001197104.2 ENSP00000436786.2

Frequencies

GnomAD3 genomes
AF:
0.0415
AC:
6321
AN:
152174
Hom.:
185
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0101
Gnomad AMI
AF:
0.00330
Gnomad AMR
AF:
0.0255
Gnomad ASJ
AF:
0.0472
Gnomad EAS
AF:
0.0310
Gnomad SAS
AF:
0.0678
Gnomad FIN
AF:
0.0817
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0574
Gnomad OTH
AF:
0.0353
GnomAD2 exomes
AF:
0.0500
AC:
12569
AN:
251238
AF XY:
0.0532
show subpopulations
Gnomad AFR exome
AF:
0.00953
Gnomad AMR exome
AF:
0.0218
Gnomad ASJ exome
AF:
0.0526
Gnomad EAS exome
AF:
0.0234
Gnomad FIN exome
AF:
0.0702
Gnomad NFE exome
AF:
0.0577
Gnomad OTH exome
AF:
0.0514
GnomAD4 exome
AF:
0.0588
AC:
85866
AN:
1461192
Hom.:
2788
Cov.:
30
AF XY:
0.0598
AC XY:
43453
AN XY:
726904
show subpopulations
African (AFR)
AF:
0.00863
AC:
289
AN:
33472
American (AMR)
AF:
0.0229
AC:
1023
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.0541
AC:
1414
AN:
26126
East Asian (EAS)
AF:
0.0469
AC:
1860
AN:
39674
South Asian (SAS)
AF:
0.0763
AC:
6577
AN:
86190
European-Finnish (FIN)
AF:
0.0654
AC:
3496
AN:
53416
Middle Eastern (MID)
AF:
0.0512
AC:
295
AN:
5764
European-Non Finnish (NFE)
AF:
0.0608
AC:
67593
AN:
1111498
Other (OTH)
AF:
0.0550
AC:
3319
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3807
7614
11421
15228
19035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2530
5060
7590
10120
12650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0415
AC:
6321
AN:
152292
Hom.:
185
Cov.:
32
AF XY:
0.0426
AC XY:
3169
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0101
AC:
420
AN:
41582
American (AMR)
AF:
0.0254
AC:
389
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0472
AC:
164
AN:
3472
East Asian (EAS)
AF:
0.0312
AC:
162
AN:
5186
South Asian (SAS)
AF:
0.0683
AC:
329
AN:
4818
European-Finnish (FIN)
AF:
0.0817
AC:
866
AN:
10600
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0574
AC:
3907
AN:
68022
Other (OTH)
AF:
0.0350
AC:
74
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
320
641
961
1282
1602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0517
Hom.:
306
Bravo
AF:
0.0363
Asia WGS
AF:
0.0430
AC:
150
AN:
3478
EpiCase
AF:
0.0559
EpiControl
AF:
0.0570

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 19, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
8.5
DANN
Benign
0.78
PhyloP100
1.8
PromoterAI
0.021
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9332801; hg19: chr11-118355642; COSMIC: COSV63283256; COSMIC: COSV63283256; API